针对晚期肺状细胞癌的免疫治疗新兴选择和未来策略
Y Wang1, R Rosell2, F R Hirsch3
1Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang, China; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
概括
先进的肺状细胞癌 (LUSC) 治疗面临着挑战. 新型免疫疗法,包括多特异性抗体和人工智能驱动的方法,有望改善患者的治疗结果并克服对当前疗法的耐药性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 晚期肺状细胞癌 (LUSC) 提出了重大的治疗挑战.
- 免疫检查点抑制剂 (ICI) 改善了LUSC治疗,但持久反应仅限于一小部分患者.
研究的目的:
- 审查新兴的免疫疗法策略,以治疗晚期LUSC.
- 概述下一代免疫疗法在LUSC治疗中的路线图.
主要方法:
- 对LUSC目前和新兴免疫疗法的文献综述.
- 探索针对个性化免疫疗法的多奥米克和人工智能方面的进展.
- 对新型治疗方法的分析,包括多特异性抗体,融合蛋白,抗体-药物合物,采用细胞疗法和癌症疫苗.
主要成果:
- 新兴的免疫疗法对LUSC患者有着早期的前景.
- 多组和人工智能通过分析瘤免疫微环境并预测治疗反应,为精确的免疫疗法提供了潜力.
- 下一代战略重点是多目标疗法和精细的患者选择.
结论:
- 皮癌治疗的未来涉及到将多目标生物疗法与创新技术相结合.
- 提高免疫细胞毒性和改善患者选择是推动LUSC免疫疗法的关键.
- 为下一代免疫疗法制定路线图对于克服LUSC治疗挑战至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


